Biofrontera (BFRI) Q4 2025 Earnings Transcript

Motley Fool Transcribing, The Motley Fool

Thu, March 19, 2026 astatine 10:17 AM CDT 20 min read

Image source: The Motley Fool.

Thursday, March 19, 2026 astatine 10 a.m. ET

• Chief Executive Officer, Chairman, and Founder — Hermann Lubbert

• Chief Commercial Officer — George Jones

• Chief Financial Officer — Fred Leffler

Need a punctuation from a Motley Fool analyst? Email [email protected]

Ben Shamsian: Thank you. Good morning, and invited to Biofrontera Inc.'s 4th fourth and afloat twelvemonth 2025 fiscal results and concern update league call. Please enactment that definite accusation discussed during today's telephone by absorption is covered nether the Safe Harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera Inc.'s absorption volition beryllium making forward-looking statements, and existent results whitethorn disagree materially from those stated oregon implied by these forward-looking statements. The risks and uncertainties associated with the company's concern are elaborate successful and are qualified by the cautionary statements contained successful Biofrontera Inc.'s property releases and SEC filings, including the company's Annual Report connected Form 10-K for the twelvemonth ended 12/31/2025.

Also, this league telephone contains time-sensitive accusation that is close lone arsenic of the day of the unrecorded broadcast. Biofrontera Inc. undertakes nary work to revise immoderate forward-looking statements to bespeak events oregon circumstances aft the day of this league call, but arsenic required by law. During today's call, determination volition beryllium references to definite non-GAAP fiscal measures. Biofrontera Inc. believes these measures supply utile accusation for investors, yet should not beryllium considered arsenic a substitute for GAAP nor should they beryllium viewed arsenic a substitute for operating results determined successful accordance with GAAP.

A reconciliation of non-GAAP to GAAP results is included successful the property merchandise issued contiguous and is besides disposable connected the company's website astatine biofronteraus.com nether the Investor Relations section. Please enactment absorption volition beryllium referencing adjusted EBITDA, a non-GAAP fiscal measurement defined arsenic nett income oregon nonaccomplishment excluding involvement income and expense, income taxes, depreciation and amortization, and definite different nonrecurring oregon noncash items, including changes successful just worth of warrant liabilities, stock-based compensation, summation connected merchantability of assets held for sale, and disbursal issuance costs. With that said, I would present similar to crook the telephone implicit to Hermann Lubbert, CEO, Chairman, and Founder of Biofrontera Inc.

Hermann Lubbert: Yes. Thank you, Ben, and convey you to everyone joining america this morning. Fiscal twelvemonth 2025 was a transformational twelvemonth for Biofrontera Inc. I americium arrogant to accidental that we delivered grounds yearly revenues of $41.7 million, representing astir 12% maturation implicit the anterior year, capped by a grounds 4th fourth successful which we generated revenues of $17.1 million, the highest quarterly gross successful our company's history, representing astir 36% year-over-year growth. These results show the spot of our commercialized execution and the increasing adoption of Ameluz PDT crossed the dermatology community. As a effect of the amendment successful the contractual narration with our erstwhile genitor company, Biofrontera AG, I volition explicate successful a fewer minutes.